Letko Brosseau & Associates Inc. Decreases Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Letko Brosseau & Associates Inc. reduced its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 10.4% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 42,950 shares of the exchange traded fund’s stock after selling 5,000 shares during the quarter. Letko Brosseau & Associates Inc. owned 0.06% of SPDR S&P Biotech ETF worth $3,868,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Demars Financial Group LLC acquired a new position in SPDR S&P Biotech ETF during the 4th quarter valued at about $280,309,000. BlueCrest Capital Management Ltd acquired a new position in shares of SPDR S&P Biotech ETF during the fourth quarter worth approximately $138,051,000. Mirae Asset Securities USA Inc. boosted its position in shares of SPDR S&P Biotech ETF by 66.7% during the fourth quarter. Mirae Asset Securities USA Inc. now owns 1,500,000 shares of the exchange traded fund’s stock worth $135,090,000 after buying an additional 600,000 shares during the period. Bessemer Group Inc. grew its holdings in SPDR S&P Biotech ETF by 5.7% in the 4th quarter. Bessemer Group Inc. now owns 1,376,834 shares of the exchange traded fund’s stock worth $123,997,000 after buying an additional 73,866 shares in the last quarter. Finally, RA Capital Management L.P. acquired a new stake in SPDR S&P Biotech ETF in the 4th quarter valued at approximately $110,615,000.

SPDR S&P Biotech ETF Trading Down 2.1%

Shares of NYSEARCA:XBI opened at $76.39 on Monday. SPDR S&P Biotech ETF has a twelve month low of $66.66 and a twelve month high of $105.47. The firm has a market cap of $4.85 billion, a P/E ratio of 11.47 and a beta of 1.00. The company has a 50 day moving average of $80.77 and a 200-day moving average of $89.16.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.